A Phase 3 Study Comparing an Ointment Containing Calcipotriol 25 mcg/g Plus Hydrocortisone 10 mg g With Tacalcitol 4 mcg/g Ointment and the Ointment Vehicle Alone, All Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and on the Intertriginous Areas
Phase of Trial: Phase III
Latest Information Update: 04 May 2015
At a glance
- Drugs Calcipotriol/hydrocortisone (Primary) ; Tacalcitol
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 04 Jul 2012 Primary outcome added as reported by European Clinical Trials Database record.
- 04 Jul 2012 Crookes Healthcare added as associations as reported in the European Clinical Trials Database record.
- 25 Dec 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.